|
GTBP GT Biopharma Inc 109657 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-2,833,000.00 |
| Balance Sheet |
|
Current Assets
|
$9,996,000.00 |
|
Assets
|
$8,106,000.00 |
|
Current Liabilities
|
$2,416,000.00 |
|
Liabilities
|
$1,321,000.00 |
|
Equity
|
$7,580,000.00 |
|
Shares Out
|
35181891.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-2,468,000.00 |
|
Investing Cash Flow
|
$12,893,000.00 |
| Market Analysis |
Market Cap
|
$10,906,386.21 |
|
Price
|
$0.29 |
|
BVPS
|
0.22 |
|
PB
|
1.41 |
|
EPS
|
-0.11 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:43 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:43 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view GTBP documents filed with the SEC.
GTBP Filings
Clear
